These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1279288)

  • 1. Placebo-controlled trial of doxazosin in management of patients with hypertension and hypercholesterolaemia.
    Macphee GJ; Curzio J; Farish E; Reid JL; Elliott HL
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):429-33. PubMed ID: 1279288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
    Hirano T; Yoshino G; Kashiwazaki K; Adachi M
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo-controlled study.
    Black HR; Sollins JS; Garofalo JL
    Am J Hypertens; 2000 May; 13(5 Pt 1):468-74. PubMed ID: 10826396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance.
    Shionoiri H; Ashino K; Yamanaka K; Shindo K; Hiroto S; Arita T
    Clin Ther; 1997; 19(3):527-36. PubMed ID: 9220217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
    Davis BR; Cutler JA; Furberg CD; Wright JT; Farber MA; Felicetta JV; Stokes JD;
    Ann Intern Med; 2002 Sep; 137(5 Part 1):313-20. PubMed ID: 12204014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
    Levy D; Walmsley P; Levenstein M
    Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
    Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
    Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
    Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I; Stokke HP
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients. The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study.
    Ferrara LA; Di Marino L; Russo O; Marotta T; Mancini M
    Hypertension; 1993 Jan; 21(1):97-104. PubMed ID: 8418030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension.
    Tamasawa N; Matsui J; Ogawa Y; Gotoh T; Hinata T; Murakami H; Zhi GJ; Suda T
    J Diabetes Complications; 2000; 14(3):135-9. PubMed ID: 10989321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
    Jones DW; Sands CD
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
    Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension.
    Derosa G; Cicero AF; Gaddi A; Mugellini A; Ciccarelli L; Fogari R
    J Cardiovasc Pharmacol; 2005 Jun; 45(6):599-604. PubMed ID: 15897788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
    Celis H; Lijnen P; Fagard R; Staessen J; Thijs L; Amery A
    J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure-lowering effect and duration of action of bedtime administration of doxazosin determined by home blood pressure measurement.
    Gonokami K; Obara T; Kobayashi M; Katada S; Hara A; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2010; 32(5):311-7. PubMed ID: 20662733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.